Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer

od Rehman, Yasser, Rosenberg, Jonathan E
Izdano 2012

The emerging role of antibody-drug conjugates in urothelial carcinoma

od Lattanzi, Michael, Rosenberg, Jonathan E
izdano v Expert Rev Anticancer Ther (2020)

Advanced Urothelial Carcinoma: Overcoming Treatment Resistance through Novel Treatment Approaches

od Bambury, Richard M., Rosenberg, Jonathan E.
Izdano 2013

Systemic, perioperative management of muscle-invasive bladder cancer and future horizons

od Funt, Samuel A., Rosenberg, Jonathan E.
izdano v Nat Rev Clin Oncol (2016)

Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma

od Wong, Jeffrey L., Rosenberg, Jonathan E.
izdano v Expert Opin Biol Ther (2021)

Novel agents for advanced bladder cancer

od Sonpavde, Guru, Elfiky, Aymen A., Rosenberg, Jonathan E.
Izdano 2009

Personalized therapy for urothelial cancer: review of the clinical evidence

od Guancial, Elizabeth A., Chowdhury, Dipanjan, Rosenberg, Jonathan E.
Izdano 2011

Developing precision medicine for bladder cancer

od Guercio, Brendan J., Iyer, Gopa, Rosenberg, Jonathan E.
izdano v Hematol Oncol Clin North Am (2021)

Update in Urothelial Carcinoma: Novel Agents and Targeted Therapy

od Guancial, Elizabeth A., Rosenberg, Jonathan E., Sweeney, Christopher J.
izdano v Am Soc Clin Oncol Educ Book (2011)

Novel molecular targets for urothelial carcinoma

od Faltas, Bishoy M., Karir, Beerinder S., Tagawa, Scott T., Rosenberg, Jonathan E.
izdano v Expert Opin Ther Targets (2015)

Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma

od Kurtoglu, Metin, Davarpanah, Nicole N., Qin, Rui, Powles, Thomas, Rosenberg, Jonathan E., Apolo, Andrea B.
izdano v Clin Genitourin Cancer (2015)

Urothelial carcinoma: Stem cells on the edge

od Brandt, William D., Matsui, William, Rosenberg, Jonathan E., He, Xiaobing, Ling, Shizhang, Schaeffer, Edward M., Berman, David M.
Izdano 2009

The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer

od van Dijk, Nick, Funt, Samuel A., Blank, Christian U., Powles, Thomas, Rosenberg, Jonathan E., van der Heijden, Michiel S.
izdano v Eur Urol (2018)

Treatment Decision Making in Patients with Bladder Cancer

od Berry, Donna L., Nayak, Manan, Halpenny, Barbara, Harrington, Shannon, Loughlin, Kevin R., Chang, Peter, Rosenberg, Jonathan E., Kibel, Adam S.
izdano v Bl Cancer (2015)

Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-invasive Urothelial Bladder Carcinoma

od Liu, David, Plimack, Elizabeth R., Hoffman-Censits, Jean, Garraway, Levi A., Bellmunt, Joaquim, Van Allen, Eliezer, Rosenberg, Jonathan E.
izdano v JAMA Oncol (2016)

Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer

od Riester, Markus, Taylor, Jennifer M., Feifer, Andrew, Koppie, Theresa, Rosenberg, Jonathan E., Downey, Robert J., Bochner, Bernard H., Michor, Franziska
Izdano 2012

The High Incidence of Vascular Thromboembolic Events in Advanced Urothelial Cancer Treated with Platinum Chemotherapy Agents

od Tully, Christopher M., Apolo, Andrea B., Zabor, Emily C., Regazzi, Ashley M., Ostrovnaya, Irina, Rosenberg, Jonathan E., Bajorin, Dean F.
izdano v Cancer (2015)

Improved 5-factor prognostic classification of patients receiving salvage systemic therapy for advanced urothelial carcinoma

od Sonpavde, Guru, Pond, Gregory R., Rosenberg, Jonathan E., Bajorin, Dean F., Choueiri, Toni K., Necchi, Andrea, Di Lorenzo, Giuseppe, Bellmunt, Joaquim
izdano v J Urol (2015)

Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical relapse after definitive local therapy for prostate cancer

od McKay, Rana R., Gray, Kathryn, Hayes, Julia H., Bubley, Glenn, Rosenberg, Jonathan E., Hussain, Arif, Kantoff, Philip W., Taplin, Mary-Ellen
izdano v Cancer (2015)

Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes

od Solovyov, Alexander, Vabret, Nicolas, Arora, Kshitij S., Snyder, Alexandra, Funt, Samuel A., Bajorin, Dean F., Rosenberg, Jonathan E., Bhardwaj, Nina, Ting, David T., Greenbaum, Benjamin D.
izdano v Cell Rep (2018)